Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK

被引：25

作者：

Shields, Adrian M. ^{[1
]}

Anantharachagan, Ariharan ^{[2
]}

Arumugakani, Gururaj ^{[3
]}

Baker, Kenneth ^{[4
,5
]}

Bahal, Sameer ^{[6
]}

Baxendale, Helen ^{[7
]}

Bermingham, William ^{[8
]}

Bhole, Malini ^{[9
]}

Boules, Evon ^{[10
]}

Bright, Philip ^{[11
]}

Chopra, Charu ^{[12
]}

Cliffe, Lucy ^{[13
]}

Cleave, Betsy ^{[13
]}

Dempster, John ^{[14
]}

Devlin, Lisa ^{[15
]}

Dhalla, Fatima ^{[16
]}

Diwakar, Lavanya ^{[17
]}

Drewe, Elizabeth ^{[13
]}

Duncan, Christopher ^{[18
]}

Dziadzio, Magdalena ^{[19
]}

Elcombe, Suzanne ^{[20
]}

Elkhalifa, Shuayb ^{[21
]}

Gennery, Andrew ^{[22
,23
]}

Ghanta, Harichandrana ^{[24
]}

Goddard, Sarah ^{[17
]}

Grigoriadou, Sofia ^{[25
]}

Hackett, Scott ^{[26
]}

Hayman, Grant ^{[27
]}

Herriot, Richard ^{[28
]}

Herwadkar, Archana ^{[21
]}

Huissoon, Aarnoud ^{[8
]}

Jain, Rashmi ^{[16
]}

Jolles, Stephen ^{[29
]}

Johnston, Sarah ^{[11
]}

Khan, Sujoy ^{[30
]}

Laffan, James ^{[27
]}

Lane, Peter ^{[1
]}

Leeman, Lucy ^{[31
]}

Lowe, David M. ^{[6
,32
]}

Mahabir, Shanti ^{[33
]}

Mac Lochlainn, Dylan James ^{[16
]}

McDermott, Elizabeth ^{[13
]}

Misbah, Siraj ^{[16
]}

Moghaddas, Fiona ^{[11
]}

Morsi, Hadeil ^{[16
]}

Murng, Sai ^{[27
]}

Noorani, Sadia ^{[34
]}

O'Brien, Rachael ^{[35
]}

Patel, Smita ^{[16
]}

Price, Arthur ^{[33
]}

机构：

[1] Univ Birmingham, Inst Immunol & Immunotherapy, Clin Immunol Serv, Birmingham, W Midlands, England

[2] Lancashire Teaching Hosp NHS Fdn Trust, Preston, Lancs, England

[3] Leeds Teaching Hosp NHS Trust, Dept Clin Immunol & Allergy, St James Univ Hosp, Leeds, W Yorkshire, England

[4] Newcastle Univ, NIHR Newcastle Biomed Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England

[5] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England

[6] Royal Free London NHS Fdn Trust, Dept Immunol, London, England

[7] Royal Papworth NHS Fdn Trust, Cambridge, England

[8] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England

[9] Dudley Grp NHS Fdn Trust, Birmingham, W Midlands, England

[10] Sheffield Teaching Hosp NHS Fdn Trust, Clin Immunol & Allergy Dept, Sheffield, S Yorkshire, England

[11] North Bristol NHS Trust, Clin Immunol, Bristol, Avon, England

[12] Royal Infirm Edinburgh NHS Trust, Dept Haematol & Immunol, NHS Lothian, Edinburgh, Midlothian, Scotland

[13] Nottingham Univ Hosp NHS Trust, Clin Immunol & Allergy Dept, Nottingham, England

[14] Univ Coll London Hosp, Specialist Allergy & Clin Immunol, London, England

[15] Royal Hosp, Reg Immunol Serv, Belfast, Antrim, North Ireland

[16] Oxford Univ Hosp NHS Fdn Trust, Dept Clin Immunol, Oxford, England

[17] Royal Stoke Hosp, Dept Immunol, Stoke On Trent, Staffs, England

[18] Newcastle Univ, Translat & Clin Res Inst, Immun & Inflammat Theme, Newcastle Upon Tyne, Tyne & Wear, England

[19] UCL, Ear Inst, London, England

[20] Newcastle Upon Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, Reg Dept Clin Immunol & Allergy, Newcastle Upon Tyne, Tyne & Wear, England

[21] Salford Royal NHS Fdn Trust, Immunol Dept, Manchester, Lancs, England

[22] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England

[23] Great North Children S Hosp, Paediat Stem Cell Transplant Unit, Newcastle Upon Tyne, Tyne & Wear, England

[24] Univ Southampton, Univ Hosp Southampton NHS Trust, Dept Allergy & Clin Immunol, Southampton, Hants, England

[25] Barts Hlth NHS Trust, Immunol Dept, Royal London Hosp, London, England

[26] Univ Hosp Birmingham, Paediat Immunol Dept, Birmingham, W Midlands, England

[27] Epsom & St Helier Univ Hosp NHS Trust, Clin Immunol Serv, South West London Immunodeficiency Ctr, London, England

[28] Aberdeen Royal Infirm, Immunol Dept, Aberdeen, Scotland

[29] Univ Hosp Wales, Immunodeficiency Ctr Wales, Heath Pk, Cardiff, Wales

[30] Hull Univ Teaching Hosp NHS Trust, Kingston Upon Hull, N Humberside, England

[31] Univ Hosp Plymouth NHS Trust, Plymouth, Devon, England

[32] UCL, Inst Immun & Transplantat, London, England

[33] Leicester Royal Infirm, Clin Immunol & Allergy Dept, Leicester, Leics, England

[34] Sandwell & West Birmingham Hosp NHS Trust, Clin Immunol Dept, Birmingham, W Midlands, England

[35] Frimley Pk Hosp, Dept Clin Immunol, Frimley, Surrey, England

[36] NHS Greater Glasgow & Clyde, Clin Immunol Serv, Glasgow, Lanark, Scotland

来源：

CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2022年 / 209卷 / 03期

关键词：

COVID-19; SARS-CoV-2; hypogammaglobulinemia; inborn errors of immunity; primary immunodeficiencies; secondary immunodeficiencies; lymphopenia; COVID-19; IMMUNITY;

D O I：

10.1093/cei/uxac008

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

In March 2020, the United Kingdom Primary Immunodeficiency Network (UKPIN) established a registry of cases to collate the outcomes of individuals with PID and SID following SARS-CoV-2 infection and treatment. A total of 310 cases of SARS-CoV-2 infection in individuals with PID or SID have now been reported in the UK. The overall mortality within the cohort was 17.7% (n = 55/310). Individuals with CVID demonstrated an infection fatality rate (IFR) of 18.3% (n = 17/93), individuals with PID receiving IgRT had an IFR of 16.3% (n = 26/159) and individuals with SID, an IFR of 27.2% (n = 25/92). Individuals with PID and SID had higher inpatient mortality and died at a younger age than the general population. Increasing age, low pre-SARS-CoV-2 infection lymphocyte count and the presence of common co-morbidities increased the risk of mortality in PID. Access to specific COVID-19 treatments in this cohort was limited: only 22.9% (n = 33/144) of patients admitted to the hospital received dexamethasone, remdesivir, an anti-SARS-CoV-2 antibody-based therapeutic (e.g. REGN-COV2 or convalescent plasma) or tocilizumab as a monotherapy or in combination. Dexamethasone, remdesivir, and anti-SARS-CoV-2 antibody-based therapeutics appeared efficacious in PID and SID. Compared to the general population, individuals with PID or SID are at high risk of mortality following SARS-CoV-2 infection. Increasing age, low baseline lymphocyte count, and the presence of co-morbidities are additional risk factors for poor outcome in this cohort. Individuals with immunodeficiency are at increased risk of severe infection. This study looks at outcomes following SARS-CoV-2 infection in 310 patients with primary or secondary immunodeficiency in the United Kingdom and finds significantly elevated mortality in both cohorts compared to the general population. Increasing age, pre-existing lymphopenia and other co-morbidities are identified as additional risk factors for death from COVID-19 in this cohort.

引用

页码：247 / 258

页数：12

共 50 条

[21] Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes
Ampuero, Javier
Lucena, Ana
Hernandez-Guerra, Manuel
Moreno-Moraleda, Isabel
Arenas, Juan
Conde, Isabel
Munoz, Laura
Canillas, Lidia
Fernandez, Edgar
Quinones, Raisa
Simon, Miguel Angel
Gomez-Dominguez, Elena
Gutierrez, Maria Luisa
Fernandez-Rodriguez, Conrado
Domper-Arnal, Maria Jose
Jorquera, Francisco
Garcia-Buey, Maria Luisa
Garcia-Retortillo, Montserrat
Morillas, Rosa
Berenguer, Marina
Casado, Marta
Morales-Arraez, Dalia
Sousa, Jose Manuel
Molina, Esther
GUT, 2022, 71 (10) : 2138 - 2140
[22] STATIN USE AND OUTCOMES IN HOSPITALIZED PATIENTS WITH SARS-COV-2 INFECTION
Siddiqi, Hasan
Vieira, Jefferson
Weber, Brittany
Kim, Andy
Rutherford, Henry
Varshney, Anubodh
Bhatt, Ankeet
Mehra, Mandeep
Woolley, Ann
Stewart, Garrick
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 3091 - 3091
[23] Perioperative Outcomes of Urological Surgery in Patients with SARS-CoV-2 Infection
McDermott, Aoibhinn
O'Kelly, John
de Barra, Eoghan
Fitzpatrick, Fidelma
Little, Dilly M.
Davis, Niall F.
EUROPEAN UROLOGY, 2020, 78 (01) : 118 - 120
[24] Pregnancy outcomes in patients with SARS-CoV-2 infection prior to delivery
Berry, Marissa J.
Wang, Amanda M.
Moutos, Christopher P.
Younes, Lena
Meilchen, Christopher
Saade, George R.
Saad, Antonio F.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (01) : S533 - S533
[25] SARS-COV-2 infection outcomes in patients with congenital generalized lipodystrophy
Madeira, Mayara Ponte
Freire, Erika Bastos Lima
Fernandes, Virginia Oliveira
da Cruz Paiva Lima, Grayce Ellen
Melo, Ivana da Ponte
Rangel Montenegro, Ana Paula Dias
da Cruz Freire, Jose Ednesio
Aquino Moreira-Nunes, Caroline De Fatima
Montenegro, Raquel Carvalho
Colares, Jeova Keny Baima
Montenegro Junior, Renan Magalhaes
DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
[26] Outcomes of cesarean delivery in obstetric patients with SARS-CoV-2 infection
Lankford, Allison
Berger, Jeffrey
Benjenk, Ivy
Jackson, Amanda
Ahmadzia, Homa
Mazzeffi, Michael
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2021, 155 (03) : 547 - 548
[27] PREVALENCE OF SARS-COV-2 INFECTION AND OUTCOMES IN GREEK SARCOIDOSIS PATIENTS
Kotsiou, Ourania S.
Kirgou, Paraskevi
Tzouvelekis, Argyrios
Kolilekas, Lykourgos
Manali, Effrosyni D.
Papiris, Spyros A.
Papakosta, Despina
Antoniou, Katerina
Papanikolaou, Ilias
Steiropoulos, Paschalis
Tomos, Ioannis
Karampitsakos, Theodoros
Levounets, Anastasia
Fouka, Evagelia
Spyropoulos, Georgios
Mastrodimou, Semeli
Papaioannou, Ourania
Kallieri, Maria
Kosmidou, Nikoleta
Bizymi, Nikoleta
Zikos, Nikolaos G.
Dimeas, Ilias E.
Malli, Foteini
Daniil, Zoe
SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2024, 41 (04)
[28] Impact of Delirium on Outcomes in Hospitalized Patients with SARS-CoV-2 Infection
Gianchandani, Sachi
Addison, Sarah
Hannawi, Yousef
Hinduja, Archana
NEUROLOGY, 2021, 96 (15)
[29] SARS-COV-2 infection outcomes in patients with congenital generalized lipodystrophy
Mayara Ponte Madeira
Erika Bastos Lima Freire
Virginia Oliveira Fernandes
Grayce Ellen da Cruz Paiva Lima
Ivana da Ponte Melo
Ana Paula Dias Rangel Montenegro
José Ednésio da Cruz Freire
Caroline de Fátima Aquino Moreira-Nunes
Raquel Carvalho Montenegro
Jeová Keny Baima Colares
Renan Magalhães Montenegro Junior
Diabetology & Metabolic Syndrome, 13
[30] APLASTIC ANAEMIA SECONDARY TO SARS-COV-2 INFECTION
Wernick, Maya
Lewis, Stacy
Moore, Christie
INTERNAL MEDICINE JOURNAL, 2021, 51 : 15 - 15

← 1 2 3 4 5 →